PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9216101

Viral hepatitis prophylaxis.

F J Carrilho·A V França·L C da Silva·A A Laudanna
View original source ↗Export metadata ↓

Abstract

Acute viral hepatitis is the most usual cause of jaundice and acute liver failure, whereas chronic viral hepatitis is the major cause of liver cirrhosis and hepatocellular carcinoma. Taking into the consideration the morbidity and mortality of such lesions, their prophylaxis is a mandatory procedure. In this review we discuss the general measures and the active and passive immunoprophylaxis against hepatitis A. B and Yellow fever, and the general management of hepatitis C. D. and E virus infection.

Explore related subjects

Hepatitis, Viral, HumanHumansImmunization, PassiveVaccinationViral Hepatitis VaccinesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F J Carrilho, A V França, L C da Silva, A A Laudanna. Viral hepatitis prophylaxis.. https://pubmed.ncbi.nlm.nih.gov/9216101/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Transfusion-transmitted virus (TTV) and renal failure].

In 1997, a new DNA virus, designated TTV "Transfusion Transmitted Virus", was isolated and seemed to be associated with non A-G post-transfusion hepatitis. The virus infects mainly patients at risk for parenteral exposure and hence, prone to develop chronic liver disease, as well as healthy populations worldwide. Few reports, however, have been published on the epidemiology and potential significance of TTV infection in patients with renal disease. This paper reviews, characterization of the virus, the history of its discovery, taxonomy and identification. Current status of TTV infection in patients with renal diseases are also summarised.

Hepatitis, Viral, Human↗
PubMed2005

Office-based approach to the implementation of a hepatitis immunization program.

To achieve high immunization levels among populations indicated to receive hepatitis A and/or B vaccine, strategies must be implemented to integrate vaccination into routine medical care. Such strategies must address the educational needs and communication skills of providers, patients' awareness of the diseases and the vaccines, the complexity of existing office systems, documentation issues including the use of immunization registries, reimbursement and third-party coverage issues, and ongoing office-based quality assurance. This article describes office-based approaches to implementing hepatitis vaccination programs and some of the tools available to facilitate this process.

Hepatitis, Viral, Human↗